10-27161062-G-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001172303.3(MASTL):c.465-32G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0682 in 1,368,716 control chromosomes in the GnomAD database, including 4,308 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.075 ( 497 hom., cov: 31)
Exomes 𝑓: 0.067 ( 3811 hom. )
Consequence
MASTL
NM_001172303.3 intron
NM_001172303.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0140
Publications
6 publications found
Genes affected
MASTL (HGNC:19042): (microtubule associated serine/threonine kinase like) This gene encodes a microtubule-associated serine/threonine kinase. Mutations at this locus have been associated with autosomal dominant thrombocytopenia, also known as thrombocytopenia-2. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Feb 2010]
MASTL Gene-Disease associations (from GenCC):
- autosomal thrombocytopenia with normal plateletsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-27161062-G-C is Benign according to our data. Variant chr10-27161062-G-C is described in ClinVar as Benign. ClinVar VariationId is 262124.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.151 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MASTL | NM_001172303.3 | c.465-32G>C | intron_variant | Intron 3 of 11 | ENST00000375940.9 | NP_001165774.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MASTL | ENST00000375940.9 | c.465-32G>C | intron_variant | Intron 3 of 11 | 1 | NM_001172303.3 | ENSP00000365107.5 | |||
| MASTL | ENST00000375946.8 | c.465-32G>C | intron_variant | Intron 3 of 11 | 1 | ENSP00000365113.4 | ||||
| MASTL | ENST00000342386.10 | c.465-32G>C | intron_variant | Intron 3 of 10 | 2 | ENSP00000343446.5 |
Frequencies
GnomAD3 genomes AF: 0.0753 AC: 11415AN: 151562Hom.: 495 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
11415
AN:
151562
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0835 AC: 20742AN: 248298 AF XY: 0.0853 show subpopulations
GnomAD2 exomes
AF:
AC:
20742
AN:
248298
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0674 AC: 81972AN: 1217036Hom.: 3811 Cov.: 17 AF XY: 0.0697 AC XY: 43081AN XY: 617688 show subpopulations
GnomAD4 exome
AF:
AC:
81972
AN:
1217036
Hom.:
Cov.:
17
AF XY:
AC XY:
43081
AN XY:
617688
show subpopulations
African (AFR)
AF:
AC:
2697
AN:
28316
American (AMR)
AF:
AC:
2786
AN:
43064
Ashkenazi Jewish (ASJ)
AF:
AC:
1815
AN:
24462
East Asian (EAS)
AF:
AC:
7988
AN:
38498
South Asian (SAS)
AF:
AC:
11658
AN:
80678
European-Finnish (FIN)
AF:
AC:
5788
AN:
53238
Middle Eastern (MID)
AF:
AC:
258
AN:
5288
European-Non Finnish (NFE)
AF:
AC:
45441
AN:
891412
Other (OTH)
AF:
AC:
3541
AN:
52080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3725
7450
11175
14900
18625
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1690
3380
5070
6760
8450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0754 AC: 11437AN: 151680Hom.: 497 Cov.: 31 AF XY: 0.0795 AC XY: 5893AN XY: 74114 show subpopulations
GnomAD4 genome
AF:
AC:
11437
AN:
151680
Hom.:
Cov.:
31
AF XY:
AC XY:
5893
AN XY:
74114
show subpopulations
African (AFR)
AF:
AC:
3846
AN:
41390
American (AMR)
AF:
AC:
784
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
AC:
268
AN:
3470
East Asian (EAS)
AF:
AC:
826
AN:
5174
South Asian (SAS)
AF:
AC:
751
AN:
4816
European-Finnish (FIN)
AF:
AC:
1133
AN:
10414
Middle Eastern (MID)
AF:
AC:
11
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3684
AN:
67874
Other (OTH)
AF:
AC:
114
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
536
1073
1609
2146
2682
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.